000151467 001__ 151467
000151467 005__ 20250310131043.0
000151467 0247_ $$2doi$$a10.1016/j.drugalcdep.2021.108808
000151467 0248_ $$2sideral$$a126212
000151467 037__ $$aART-2021-126212
000151467 041__ $$aeng
000151467 100__ $$aGonzález-Roz A.
000151467 245__ $$aDepression symptom profiles and long-term response to cognitive behavioral therapy plus contingency management for smoking cessation
000151467 260__ $$c2021
000151467 5060_ $$aAccess copy available to the general public$$fUnrestricted
000151467 5203_ $$aBackground: Depression is heterogeneous in nature and using diagnostic categories limits insight into understanding psychopathology and its impact on treatment efficacy. This secondary analysis sought to: 1) identify distinct subpopulations of cigarette users with depression, and 2) examine their response to cognitive-behavioral treatment (CBT) + contingency management (CM) for smoking cessation at one year. Method: The sample comprised 238 (74 % females) adults who smoke receiving CBT only or CBT + CM. A latent class analysis was conducted on baseline depressive symptoms measured using the Beck Depression Inventory-II. Generalized estimating equations assessed the main and interactive effects of class, time, treatment, and sex on smoking abstinence. Results: Three distinct classes were identified: C1 (n= 76/238), characterized by mild depression, loss of energy, pessimism, and criticism, C2 (n= 100/238) presenting moderate severity and decreased appetite, and C3 (n= 62/238) showing severe depression, increased appetite, and feelings of punishment. There was a significant cluster × treatment interaction, which indicated additive effects of CM over CBT alone for Class 1 and 2. Persons in Class 1 and 2 were 3.60 [95 % CI: 1.62, 7.97] and 2.65 [95 % CI: 1.19, 5.91] times more likely to be abstinent if CBT + CM was delivered rather than CBT only. No differential sex effects were observed on treatment response according to cluster. Conclusions: Profiling depression symptom subtypes of cigarette users may be more informative to improve CM treatment response than merely focusing on total scores.
000151467 536__ $$9info:eu-repo/grantAgreement/ES/MICINN/BES-2016-076663$$9info:eu-repo/grantAgreement/ES/MICINN/PSI2015-64371-P
000151467 540__ $$9info:eu-repo/semantics/openAccess$$aby$$uhttp://creativecommons.org/licenses/by/3.0/es/
000151467 590__ $$a4.852$$b2021
000151467 591__ $$aSUBSTANCE ABUSE$$b8 / 37 = 0.216$$c2021$$dQ1$$eT1
000151467 591__ $$aPSYCHIATRY$$b44 / 143 = 0.308$$c2021$$dQ2$$eT1
000151467 591__ $$aPSYCHIATRY$$b61 / 155 = 0.394$$c2021$$dQ2$$eT2
000151467 591__ $$aSUBSTANCE ABUSE$$b6 / 21 = 0.286$$c2021$$dQ2$$eT1
000151467 592__ $$a1.438$$b2021
000151467 593__ $$aPharmacology$$c2021$$dQ1
000151467 593__ $$aToxicology$$c2021$$dQ1
000151467 593__ $$aPharmacology (medical)$$c2021$$dQ1
000151467 594__ $$a6.1$$b2021
000151467 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion
000151467 700__ $$aSecades-Villa R.
000151467 700__ $$aGarcía-Fernández G.
000151467 700__ $$0(orcid)0000-0002-0403-5273$$aMartínez-Loredo V.$$uUniversidad de Zaragoza
000151467 700__ $$aAlonso-Pérez F.
000151467 7102_ $$14009$$2680$$aUniversidad de Zaragoza$$bDpto. Psicología y Sociología$$cÁrea Person.Eval.Trat.Psicoló.
000151467 773__ $$g225 (2021), 108808 [7 pp.]$$pDrug alcohol depend.$$tDrug and Alcohol Dependence$$x0376-8716
000151467 8564_ $$s502303$$uhttps://zaguan.unizar.es/record/151467/files/texto_completo.pdf$$yVersión publicada
000151467 8564_ $$s2466498$$uhttps://zaguan.unizar.es/record/151467/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada
000151467 909CO $$ooai:zaguan.unizar.es:151467$$particulos$$pdriver
000151467 951__ $$a2025-03-10-12:56:17
000151467 980__ $$aARTICLE